These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1562122)

  • 21. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
    Lawrence CL; Pollard CE; Hammond TG; Valentin JP
    J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced torsades de pointes--a form of mechano-electric feedback?
    Fabritz L
    Cardiovasc Res; 2007 Nov; 76(2):202-3. PubMed ID: 17869232
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes.
    Bar-Meir E; Schein O; Eisenkraft A; Rubinshtein R; Grubstein A; Militianu A; Glikson M;
    Crit Rev Toxicol; 2007 Mar; 37(3):279-85. PubMed ID: 17453935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic and electrophysiologic effects of ontazolast in dogs.
    Hamlin RL; Nakayama T; Brady JT; Stoll RE
    Am J Vet Res; 2000 Nov; 61(11):1364-8. PubMed ID: 11108180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Late" proarrhythmia due to quinidine.
    Oberg KC; O'Toole MF; Gallastegui JL; Bauman JL
    Am J Cardiol; 1994 Jul; 74(2):192-4. PubMed ID: 8023791
    [No Abstract]   [Full Text] [Related]  

  • 30. Bretylium tosylate versus lidocaine in experimental cardiac arrest.
    Vachiery JL; Reuse C; Blecic S; Contempré B; Vincent JL
    Am J Emerg Med; 1990 Nov; 8(6):492-5. PubMed ID: 2222590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.
    Al-Sardar H
    Br J Hosp Med (Lond); 2007 Apr; 68(4):221; author reply 221. PubMed ID: 17469230
    [No Abstract]   [Full Text] [Related]  

  • 32. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acquired long QT syndrome and cardiac arrest after general anesthesia. Case report and review of literature].
    Leclercq T; Parrel S; Mierdl S; Cottin Y; Girard C
    Ann Fr Anesth Reanim; 2014 Jun; 33(6):421-6. PubMed ID: 24880555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced QT prolongation and sudden death.
    Del Rosario ME; Weachter R; Flaker GC
    Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs causing prolongation of QT interval and torsades de pointes.
    CMAJ; 1998 Jan; 158(1):103-4, 107-8. PubMed ID: 9475921
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged QT: A rare cause of cardiac arrest.
    Carlquist J
    JAAPA; 2015 Jul; 28(7):1-4. PubMed ID: 26309914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block.
    Watanabe O; Okumura T; Takeda H; Nakamura W; Segawa K; Ito H; Yoshimoto N
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):686-8. PubMed ID: 10234727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.